The global allogeneic stem cells market size has the potential to grow by USD 1.24 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period because of the steady increase in year-over-year growth.
This report provides a detailed analysis of the market by application (regenerative therapy and drug discovery and development) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., Lineage Cell Therapeutics Inc., MEDIPOST Co. Ltd., MiMedx Group Inc., Osiris Therapeutics Inc., Stempeutics Research Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd.
Browse TOC and LoE with selected illustrations and example pages of allogeneic stem cells market
The allogeneic stem cells market is concentrated, and the degree of concentration will remain the same during the forecast period. The key players in the market are focusing on various growth strategies, including M&A, divestitures, JVs, and partnerships to expand geographical reach and increase their market share. Osiris Therapeutics Inc., Stempeutics Research Pvt. Ltd., and Takeda Pharmaceutical Co. Ltd. are some of the major market participants. Although the new product approvals will offer immense growth opportunities, the high cost of allogeneic stem cell therapies will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this allogeneic stem cells market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this allogeneic stem cells market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading allogeneic stem cells companies, including:
Biosolution Co. Ltd.
Cynata Therapeutics Ltd.
JCR Pharmaceuticals Co. Ltd.
Lineage Cell Therapeutics Inc.
MEDIPOST Co. Ltd.
MiMedx Group Inc.
Osiris Therapeutics Inc.
Stempeutics Research Pvt. Ltd.
Takeda Pharmaceutical Co. Ltd.
Allogeneic Stem Cells Market: Segmentation by Region
North America was the largest market for allogeneic stem cells in 2019 and the region will offer several growth opportunities to market vendors during the forecast period. The increasing prevalence of various cancers, including leukemia and the availability of advanced healthcare infrastructure are some of the factors that will significantly influence the growth of allogeneic stem cells market in the region.
About 52% of the market’s growth will originate from North America during the forecast period. The US is one of the critical markets for allogeneic stem cells in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.
Allogeneic Stem Cells Market: Segmentation by Application
The healthcare industry is majorly shifting toward biologics and regenerative therapies for the treatment of a wide array of medical conditions. Regenerative medicine focuses on the functional restoration of tissues or organs for patients with severe injuries or chronic diseases. Moreover, the progress in the field of stem cell research is leading to an increase in the scope of stem cell applications in regenerative therapeutics.
Market growth in this segment will be faster than the growth of the market in the drug discovery and development segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the allogeneic stem cells market size.
Allogeneic Stem Cells Market: Key Drivers and Trends
The launch of new product lines provides better options to buyers and stimulates the product demand for stem cell therapies, including allogeneic stem cell therapies. The rising demand for regenerative medicines is encouraging manufacturers to emphasize on continuous innovations and improvisations in the development of improved therapies. Additionally, these therapeutic candidates have the approval of clinical trials in the US. Because of the efficacy of allogeneic stem cell therapeutics, these are expected to receive marketing approvals from the US FDA which will significantly influence allogeneic stem cells market growth over the forecast period.
The research in the field of stem cell mainly focuses on developing new treatments for deadly diseases, which have negligible treatment using traditional treatment options.
The therapeutic candidates, which are under development, have been awarded special drug designations by regulatory bodies making it one of the critical allogeneic stem cells market trends.
Drug designations enhance the research and enable drugs to reach the market and provides strong incentives, which in turn, encourages vendors to expedite R&D on novel therapies such as allogeneic stem cell therapy.
Fast track drug designation is granted for accelerated evaluation to simplify the development of drugs that treats a life-threatening condition and help in meeting the unmet medical need.
During 2020-2024, the market will grow at a CAGR of over 12%.